TITLE:
Ventricular Non-Compaction: About the First Cases Reported in Lomé (Togo)
AUTHORS:
Soodougoua Baragou, Soulemane Pessinaba, Tchalla Abéna, Ekpé Togbossi, Wiyaou Kaziga, Komlavi Yayehd, Mohamed Kpélafia, Nkenon Watani N’Da, El Nassirine Oloudé, Machihude Pio, Findibe Damorou
KEYWORDS:
Ventricular Non-Compaction, Hypertrophy, Sub-Saharan Africa, Heart Failure, Togo
JOURNAL NAME:
World Journal of Cardiovascular Diseases,
Vol.10 No.12,
December
10,
2020
ABSTRACT:
Introduction: Ventricular non-compaction, a cardiomyopathy recently described as likely to be rare, belongs to the group of unclassified cardiomyopathy according to European Society of Cardiology. Few studies have been published on the ventricular non-compaction in sub-Saharan Africa. We aimto find out the various aspects, being diagnosis, therapeutic, in Togolese patients carrying the ventricular non-compaction. Methodology: This is a three-year prospective and descriptive study conducted from January 2017 to December 2019 in the two University Hospital of Lomé. Patients having echocardiographic criteria of ventricular non-compaction were included in our study. Results: 10 patients (6 men and 4 women) were diagnosed for ventricular non-compaction during the study period. The mean age of patients was 32.3 years. The most frequent clinical manifestation was heart failure (7 patients). The main electrocardiogram anomaly was left ventricle hypertrophy(9 patients). The preferential segments were: apical (9 cases), apicolateral (8 cases), and septoapical (7 cases). The average ratio of non-compaction/compactionwas 3.31. The main complication was thromboembolic event (4 patients). Angiotensin converting enzyme inhibitors and beta-blockers were essentially the medicines used. After a three (3) year follow-up, two (2) of the patients died. Conclusion: Tough ventricular non-compaction has been recently described. It is present in Togo. It displays many clinical manifestations and the prognosis is often guarded.